Hot News

A WORKSHOP WILL BE HELD WITHIN THE SCOPE OF THE PHARMACEUTICAL SECTOR INQUIRY. (21.09.2026)			31.8.2026
The Preliminary Report prepared as part of the Pharmaceutical Sector Inquiry conducted by the Turkish Competition Authority with a view to assessing, from a holistic perspective, the competition concerns arising across the pharmaceutical sector’s value chain, extending from research and development and manufacturing to licensing, reimbursement, distribution, and the delivery of medicines to patients, was published on 10 August 2026. Under the inquiry, the competitive structure of the pharmace...
Read

Acquisition of sole control over Warner Bros. Discovery Inc. By Paramount Skydance Corporation authorized, subject to conditions			29.8.2026
With the decision dated 20.08.2026 and numbered 26-30/866-361, the Competition Board (Board) granted conditional authorization to the transaction involving the acquisition of sole control over Warner Bros. Discovery Inc. (WARNER BROS) by Paramount Skydance Corporation (PARAMOUNT), subject to the commitments submitted by PARAMOUNT. The file identified certain instances of horizontal and vertical overlap between the activities of PARAMOUNT and WARNER BROS. The file assessed the commitments offe...
Read

Investigation Launched on Undertakings Operating in the Plant Protection or Plant Nutrition Products Market			28.8.2026
In accordance with the Competition Board Decision dated 06.08.2026 and numbered 26-28/802-M, an investigation has been launched on undertakings operating in the plant protection or plant nutrition products market, including Adama Turkey Tarım Sanayi ve Ticaret Ltd Şti., Agrobest Grup Tarım İlaçları Tohumculuk İmalat İthalat İhracat Sanayi ve Ticaret AŞ, Agrofarm Kimya Sanayi ve Ticaret AŞ, AMC-TR Tarım Sanayi ve Ticaret AŞ, Astranova Tarım Ticaret ve Sanayi AŞ, BASF Agricultural Solutions Turkey...
Read

Investigation Launched on TEVA.			21.8.2026
The Competition Board (Board) concluded the preliminary inquiry conducted in order to determine if Teva İlaçları San. ve Tic. AŞ (TEVA) violated Article 6 of the Act no 4054 on the Protection of Competition (Act no 4054) by engaging in conduct intended to restrict competition from generic medicines, through the strategic use of divisional patent procedures and creation of a misleading impression before healthcare authorities regarding the efficacy and safety of competing products. The Board l...
Read

Pharmaceutical Sector Inquiry Preliminary Report Published			10.8.2026
According to the Competition Board decision dated 08.12.2021 and numbered 21-59/844-M, a sector inquiry was initiated to detect the structural competition problems in the pharmaceutical sector and offer competitive solutions. The pharmaceutical sector, due to its structural characteristics and features that are different from other sectors, is among the sectors that competition authorities prioritize both in Türkiye and around the world. Therefore, proactive identification and assessment of t...
Read

The acquisition of CARREFOURSA by A101 conditionally authorized			6.8.2026
The Competition Board (the Board) has conditionally authorized the acquisition by Yeni Mağazacılık AŞ (A101) of the sole control of Carrefoursa Carrefour Sabancı Ticaret Merkezi AŞ (CARREFOURSA) with the decision dated 30.07.2026 and numbered 26-27/789-331 within the framework of the commitment package submitted by A101 including both behavioral and structural commitments.  The decision determines that the transaction is an acquisition subject to authorization according to article 7 of the Ac...
Read

Investigation Conducted on the economic unity composed of Avixa İlaç San. ve Tic. AŞ and Avigem İlaç San. ve Tic. Ltd. Şti. concluded through the commitment and settlement procedures.			4.8.2026
The investigation which evaluated the conduct of the economic unity composed of Avixa İlaç San. ve Tic. AŞ and Avigem İlaç San. ve Tic. Ltd. Şti. (AVIXA) involving its refusal to offer to the market one of the two nasal sprays that it distributed under the scope of the co-marketing agreement, thereby preventing the entry of competitors into the double action nasal spray market and causing public losses, with respect to Article 6 of the Act no 4054 on the Protection of Competition has been conclu...
Read

Investigation Launched on Undertakings Operating in the Nuclear Medicine Market			28.7.2026
According to the Competition Board decision dated 30.04.2026 and numbered 26-16/481-M, an investigation has been launched on Medicheck Nükleer Ürünler San. ve Tic. AŞ, Referans Nükleer Tıp Sağlık Ltd. Şti., Fefa Nükleer Tıp Ticaret Ltd. Şti., Sintias Moleküler Sağlık Ürünleri San. ve Tic. AŞ, Sintias Nükleer Tıp Tic. Ltd. Şti., Nukleon Nükleer Teknoloji Araştırma San. ve Tic. Ltd. Şti., Bianco Sağlık Ürünleri Ticaret Pazarlama Ltd. Şti., Nukleus Sağlık Hizmetleri AŞ, MNT Sağlık Hizmetleri ve Tic...
Read

The acquisition of PNS by Cargill conditionally authorized			16.7.2026
The Competition Board (the Board), with the decision dated 30.06.2026 and numbered 26-23/685-275, conditionally authorized the acquisition by Cargill Tarım ve Gıda Sanayi Ticaret AŞ (CARGILL TÜRKİYE) of PNS Pendik Nişasta Sanayi AŞ's sole control from Alpinvest Yatırım Gıda Sanayi ve Ticaret AŞ within the framework of the behavioral commitments offered by the parties.  The decision includes the findings that the transaction is an acquisition subject to authorization according to article 7 of ...
Read

Interim Measures Imposed on Haribo			3.7.2026
Within the framework of the investigation initiated on Haribo Şekerleme San. ve Tic. Ltd. Şti. (HARIBO) in accordance with Competition Board (Board) decision dated 05.03.2026 and numbered 26-08/238-M to determine if Articles 4 and 6 were of the Act no 4054 on the Protection of Competition were violated, it was decided that interim measures should be imposed on HARİBO with the Board decision dated 04.06.2026 and numbered 26-20/605-241. The decision concerned ruled that In order to preven...
Read